Director · Ovid Therapeutics Inc. · Ovid Therapeutics Inc. — Stock Option (right to buy)
Side
A
Value
—
Shares
130.0K
Price
—
Executed
Jun 15, 2026
Disclosed
Jun 17, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jun 15 executedJun 17, 2026 disclosed
OVID · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Ovid Therapeutics Inc. — Stock Option (right to buy)
Ticker
OVID
Shares
130.0K
Price per share
$0
Execution date (reported)
Jun 15, 2026
Owned after transaction
130.0K shares
Days from execution to publication
2
What this establishes
Greka Anna filed this Form 4 reporting a grant or award of OVID on Jun 15, 2026. It became public on Jun 17, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Greka Annacik:0002138163
Issuer
Ovid Therapeutics Inc.cik:0001636651
Revision history · 0
No field has changed since this record was first ingested.
